Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

C. Michael Gibson, M.D.

Concepts (195)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angioplasty, Balloon, Coronary17201218802.400 Why?
Myocardial Infarction332022118901.680 Why?
Acute Coronary Syndrome15202423651.570 Why?
Coronary Circulation12201315771.460 Why?
Platelet Aggregation Inhibitors21202432001.390 Why?
Thrombolytic Therapy9201121081.190 Why?
Morpholines320145831.030 Why?
Thiophenes320145870.940 Why?
Fibrinolytic Agents10202121670.790 Why?
Electrocardiography12201464150.780 Why?
Purinergic P2Y Receptor Antagonists1020243790.730 Why?
Ticlopidine620178950.710 Why?
Coronary Angiography14202145630.670 Why?
Aspirin10202333640.640 Why?
Electrocardiography, Ambulatory220145780.610 Why?
Stents6202133030.580 Why?
Hemorrhage9202435990.530 Why?
Intercostal Nerves12013270.450 Why?
Coronary Occlusion220143090.440 Why?
Drug Therapy, Combination13202364980.430 Why?
Myocardial Ischemia3201621640.420 Why?
No-Reflow Phenomenon12012170.410 Why?
Denervation120132770.400 Why?
Coronary Artery Disease5202166590.400 Why?
Vitamin K120143210.400 Why?
Adenosine220168340.390 Why?
Immunoglobulin Fab Fragments220114650.370 Why?
Bilirubin120134380.370 Why?
Myocardial Reperfusion220023470.370 Why?
Platelet Glycoprotein GPIIb-IIIa Complex320106380.360 Why?
Anticoagulants5202148970.360 Why?
Atrial Fibrillation3202152090.350 Why?
Drug-Eluting Stents120177570.350 Why?
Polymers1201716210.340 Why?
Enoxaparin220083970.320 Why?
Cryosurgery120134750.310 Why?
Platelet Count220117770.300 Why?
Heptanoic Acids120093470.300 Why?
Pravastatin120093930.300 Why?
Coronary Thrombosis120114860.290 Why?
Adenosine Monophosphate220212830.280 Why?
Hyperemia120082210.280 Why?
Peptides4201043540.270 Why?
Treatment Outcome252023649810.270 Why?
Cyclooxygenase Inhibitors120083640.270 Why?
Monitoring, Physiologic1201417840.270 Why?
Hospital Mortality6201254180.260 Why?
Thrombectomy120117080.260 Why?
Uric Acid120118070.250 Why?
Ventricular Fibrillation120085390.250 Why?
Thrombosis3202130510.250 Why?
Defibrillators, Implantable1201414990.240 Why?
Vascular Patency220059010.230 Why?
Arrhythmias, Cardiac1201422550.230 Why?
Lymphocytes1201226110.230 Why?
Randomized Controlled Trials as Topic122022103430.220 Why?
Heart Rupture, Post-Infarction12003480.220 Why?
Pyrroles1200911370.220 Why?
Pulsatile Flow120043210.210 Why?
Middle Aged3020212203590.200 Why?
Tissue Plasminogen Activator3200411900.200 Why?
Registries4202184580.200 Why?
Coronary Stenosis220058200.190 Why?
Double-Blind Method82017124270.180 Why?
Heparin1200816520.180 Why?
Emergency Medical Services2201119250.180 Why?
Humans5620247606130.180 Why?
Ischemia1200818930.170 Why?
Creatine Kinase120026910.170 Why?
Male3120213597180.170 Why?
Neutrophils1201237670.170 Why?
Blood Platelets1201025190.160 Why?
Antithrombins320163130.160 Why?
Tachycardia, Ventricular1200813030.160 Why?
Female3120213912460.160 Why?
Anti-Inflammatory Agents, Non-Steroidal1200822820.150 Why?
Aged2220211691430.150 Why?
Tyrosine1200214380.150 Why?
Follow-Up Studies72021392620.140 Why?
Postoperative Hemorrhage120214220.140 Why?
Isoenzymes1200216900.140 Why?
Prospective Studies72016543060.130 Why?
Antibodies, Monoclonal2201191850.130 Why?
Secondary Prevention4201615480.130 Why?
Dose-Response Relationship, Drug32017108260.120 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors1200933320.120 Why?
Postoperative Complications22017156790.120 Why?
Coronary Disease2201359910.110 Why?
Prognosis62021296610.100 Why?
Clinical Trials, Phase II as Topic120146290.100 Why?
Angina, Unstable220089260.090 Why?
Turkey120112480.090 Why?
Infusions, Intra-Arterial120112210.090 Why?
Transportation of Patients120111760.090 Why?
Administration, Oral2201740350.090 Why?
Coronary Vessels1200231120.090 Why?
Injections, Intra-Arterial120101820.090 Why?
Lymphocyte Count120127800.090 Why?
C-Reactive Protein2201238390.090 Why?
Hirudins120111940.090 Why?
Risk Assessment42021241020.080 Why?
Multivariate Analysis32012121590.080 Why?
Time and Motion Studies120081430.080 Why?
Time Factors72021401390.080 Why?
Drug Dosage Calculations120081180.080 Why?
Blood Flow Velocity2200213770.080 Why?
Endpoint Determination120115970.080 Why?
Contrast Media1200153050.070 Why?
Injections, Intravenous1201013850.070 Why?
Drug Administration Schedule2200848990.070 Why?
Artificial Intelligence1202125570.070 Why?
Diagnostic Tests, Routine120137860.070 Why?
Neuralgia120135990.070 Why?
Nerve Block120136880.070 Why?
Survival Rate32017128100.070 Why?
Statistics, Nonparametric2200228520.070 Why?
Confidence Intervals1201229320.070 Why?
Embolism120104080.070 Why?
Comorbidity22012105530.060 Why?
Ultrasonography, Interventional1201315010.060 Why?
Survival Analysis32011101850.060 Why?
Incidence42021213910.060 Why?
Regional Blood Flow1200814900.060 Why?
Infusions, Intravenous2201722350.060 Why?
Hospitalization12024107890.060 Why?
Efficiency, Organizational120086970.060 Why?
Plasminogen Activators120041990.060 Why?
Magnetic Resonance Imaging, Cine1201110460.060 Why?
Cardiovascular Diseases12009157600.060 Why?
Coronary Artery Bypass2202222720.050 Why?
Stroke2202299520.050 Why?
Adult720162200070.050 Why?
Guideline Adherence1201322830.050 Why?
Medicare1202167850.050 Why?
Atherectomy12002400.050 Why?
Recurrence2200684830.050 Why?
Regression Analysis1201263590.050 Why?
Cardiology1201317230.050 Why?
Creatine Kinase, MB Form120022110.050 Why?
Collateral Circulation120022920.050 Why?
Pyridines1201328790.050 Why?
Adolescent32016878090.050 Why?
Societies, Medical1201339050.050 Why?
Recombinant Proteins1201165380.050 Why?
Retrospective Studies42014803450.040 Why?
Echocardiography1201349810.040 Why?
Angiography, Digital Subtraction120013340.040 Why?
Exercise Test1200721280.040 Why?
Diagnosis, Differential12014129680.040 Why?
Adrenergic beta-Antagonists1200412590.040 Why?
Patient Selection1201142790.040 Why?
Peptide Fragments1201151320.040 Why?
Fishes120216010.040 Why?
Disease-Free Survival1200868310.040 Why?
Angiotensin-Converting Enzyme Inhibitors1200415230.040 Why?
Models, Cardiovascular120039770.040 Why?
Pericardium120026750.040 Why?
Statistics as Topic1200423620.040 Why?
Kaplan-Meier Estimate1200865440.040 Why?
Young Adult22016587480.030 Why?
Chi-Square Distribution1200234650.030 Why?
Combined Modality Therapy1200885520.030 Why?
History, Ancient120162110.030 Why?
United States42021724480.030 Why?
Practice Guidelines as Topic1201374750.030 Why?
Predictive Value of Tests12012152860.030 Why?
Costs and Cost Analysis1202116770.030 Why?
Risk Factors42013743330.030 Why?
Equipment Design1200335200.030 Why?
Research Design1201161800.030 Why?
Fluorescent Dyes1200219130.030 Why?
Analysis of Variance1200262380.030 Why?
Proportional Hazards Models12008125310.030 Why?
Evidence-Based Medicine2201636960.030 Why?
Diabetes Mellitus1201158900.030 Why?
Heart Rate1200441800.030 Why?
Drug Delivery Systems1200322210.020 Why?
Linear Models1200258770.020 Why?
Severity of Illness Index12008158400.020 Why?
History, 21st Century1201615750.020 Why?
Mortality1202129160.020 Why?
Cohort Studies12012413370.020 Why?
History, 20th Century1201627730.020 Why?
Hospitals1202139280.020 Why?
Stroke Volume1200155230.020 Why?
International Cooperation1201314330.020 Why?
Cause of Death1201737250.020 Why?
Cooperative Behavior1201315000.020 Why?
Terminology as Topic1201315350.020 Why?
Pandemics1202486230.010 Why?
Heart Failure12008118480.010 Why?
Consensus1201331130.010 Why?
Logistic Models12011133120.010 Why?
Aged, 80 and over12021589800.010 Why?
Animals120211679600.010 Why?
Gibson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (195)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.